Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
07/01/2023 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Stock Option (Right to Buy) | 50k | $1.41 | $70.5k | | 07/01/2023 |
06/14/2023 | Oncocyte Corp | OCX | Purchase | Common Stock, no par value | 30k | $0.21 | $6.4k | | 06/14/2023 |
12/22/2022 | Oncocyte Corp | OCX | Purchase | Common Stock, no par value | 25k | $0.29 | $7.1k | | 12/22/2022 |
08/15/2022 | Oncocyte Corp | OCX | Grant | Option to Purchase Common Stock | 45k | $0.97 | $43.6k | | 08/15/2022 |
08/15/2022 | Oncocyte Corp | OCX | Purchase | Common Stock, no par value | 5k | $0.97 | $4.8k | | 08/15/2022 |
08/15/2022 | Oncocyte Corp | OCX | Grant | | 10k | $0.00 | $0 | | 08/15/2022 |
07/01/2022 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Stock Option (right to buy) | 50k | $1.57 | $78.5k | | 07/01/2022 |
06/24/2022 | Oncocyte Corp | OCX | Exercise | Restricted Stock Units | 10k | $0.00 | $0 | | 06/24/2022 |
07/01/2021 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Stock Option (right to buy) | 80k | $2.86 | $228.8k | | 07/01/2021 |
06/24/2021 | Oncocyte Corp | OCX | Grant | Restricted Stock Units | 10k | $0.00 | $0 | | 06/24/2021 |
06/24/2021 | Oncocyte Corp | OCX | Grant | Option to Purchase Common Stock | 45k | $5.46 | $245.7k | | 06/24/2021 |
06/22/2021 | Lineage Cell Therapeutics, Inc. | BTX | Exercise | Stock Option (right to buy) | 61.8k | $2.20 | $136k | | 06/22/2021 |
12/28/2020 | Oncocyte Corp | OCX | Exercise | Option to purchase common stock | 65.3k | $1.34 | $87.5k | | 12/23/2020 |
12/23/2020 | Oncocyte Corp | OCX | Sale | Common Stock, no par value | 900 | $2.55 | $2.3k | | 12/23/2020 |
12/23/2020 | Oncocyte Corp | OCX | Exercise | Option to purchase common stock | 1.2k | $1.34 | $1.7k | | 12/23/2020 |
12/22/2020 | Oncocyte Corp | OCX | Exercise | Option to purchase common stock | 10.5k | $1.34 | $14.1k | | 12/21/2020 |
12/22/2020 | Oncocyte Corp | OCX | Sale | Common Stock, no par value | 7.7k | $0.00 | $0 | | 12/21/2020 |
12/21/2020 | Oncocyte Corp | OCX | Exercise | Option to purchase common stock | 48k | $1.34 | $64.3k | | 12/21/2020 |
12/21/2020 | Oncocyte Corp | OCX | Sale | Common Stock, no par value | 30k | $0.00 | $0 | | 12/21/2020 |
12/21/2020 | Oncocyte Corp | OCX | Sale | Common Stock, no par value | 5.1k | $2.54 | $13.1k | | 12/21/2020 |
12/11/2020 | Oncocyte Corp | OCX | Grant | Common Stock | 5.9k | $0.00 | $0 | | 12/11/2020 |
07/01/2020 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Stock Option (Right to Buy) | 70k | $0.83 | $57.8k | | 07/01/2020 |
06/17/2020 | Oncocyte Corp | OCX | Grant | Option to purchase common stock | 57k | $2.38 | $135.7k | | 06/17/2020 |
07/17/2019 | Oncocyte Corp | OCX | Grant | Option to Purchase Common Stock | 45k | $2.12 | $95.4k | | 07/17/2019 |
07/01/2019 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Stock Option (Right to Buy) | 70k | $1.03 | $72.1k | | 07/01/2019 |
03/08/2019 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Common Shares, no par value | 6.4k | $0.00 | $0 | | 03/08/2019 |
08/30/2018 | Oncocyte Corp | OCX | Grant | Option to Purchase Common Stock | 45k | $2.40 | $108k | | 08/30/2018 |
07/01/2018 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Option to Purchase Common Shares | 70k | $2.06 | $144.2k | | 07/01/2018 |
08/17/2017 | Lineage Cell Therapeutics, Inc. | BTX | Disposition | Common Shares, no par value | 300k | $2.81 | $843k | | 08/17/2017 |
07/31/2017 | Lineage Cell Therapeutics, Inc. | BTX | Sale | Common Shares, no par value | 150k | $2.80 | $420k | | 07/31/2017 |
07/01/2017 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Option to Purchase Common Shares | 50k | $3.15 | $157.5k | | 07/01/2017 |
06/15/2017 | Oncocyte Corp | OCX | Grant | Option to Purchase Common Stock | 50k | $5.10 | $255k | | 06/15/2017 |
06/15/2017 | Oncocyte Corp | OCX | Grant | Option to Purchase Common Stock | 16.3k | $5.10 | $83.1k | | 06/15/2017 |
01/03/2017 | Lineage Cell Therapeutics, Inc. | BTX | Other (disposition) | Common Shares, no par value | 238.5k | $0.00 | $0 | By Greenbelt Corp. | 01/03/2017 |
07/01/2016 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Option to Purchase Common Shares | 50k | $2.72 | $136k | | 07/01/2016 |
|